1.	Phase III Randomized Study of Three Different Thoracic Radiotherapy Regimens in Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CALGB-30610, CALGB 30610, RTOG 0538, NCT00632853
2.	Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: NCI Protocol IDs: CINJ-3330, NCT00161187
3.	Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-065, NCT00740636
4.	Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: GRID, NCT00765570
5.	Study of XL184 in Adults With Advanced Malignancies Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: XL184-203, NCT00940225
6.	A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A6012212US, NCT00951613
7.	Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer Phase: Phase I Type: Treatment Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: ID00-123, NCT00059605
8.	Hypofractionated Radiotherapy for Lung Cancer Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RO04502, NCT00214123
9.	Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06C.549, NCT00437372
10.	A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Small Cell Lung Cancer (SCLC) Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: M10-234, NCT00878449
11.	Her2 and TGFBeta in Treatment of Her2 Positive Lung Malignancy Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 24486 HERCREEM, NCT00889954
12.	Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Pro00017361, NCT00921739
13.	Study of Percutaneous Thoracic Cryotherapy in Patients With Inoperable Primary Lung Cancer or Lung Metastases Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: WSU-C-2975, WSU-0509002942, NCT00303901
14.	Respiratory Tumor and Normal Tissue Motion Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2003-0962, NCT00415675
15.	A Proof-of-Concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GE-135-003, NCT00565721
16.	Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot Study Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HSC-2007-0109, NCT00585819
17.	Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors Phase: No phase specified Type: Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: IRB # 502-2005, NCT00632281
18.	A Natural History Study of Patients Receiving High-Dose Rate Brachytherapy Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 to 90 Sponsor: NCI Protocol IDs: 090100, 09-C-0100, NCT00924027